2026-06-14T05:05:21Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/160062025-06-09T14:45:03Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19609

00925njm 22002777a 4500 dc Verweij, Paul E author Arendrup, Maiken Cavling author Alastruey-Izquierdo, Ana author Gold, Jeremy A W author Lockhart, Shawn R author Chiller, Tom author White, P Lewis author 2022-12 Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals. Drug Resist Updat. 2022 Dec;65:100885. 10.1016/j.drup.2022.100885 1532-2084 Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 36283187 http://hdl.handle.net/20.500.12105/16006 Aspergillus fumigatus DHODH inhibitor One Health Olorofim Triazole resistance Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?